Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
4.03(c) 4.23(c) 4.14(c) 4.16(c) 4.44(c) Last
824 304 800 490 1 579 811 1 002 846 958 661 Volume
+0.75% +4.96% -2.13% +0.48% +6.73% Change
More quotes
Financials ($)
Sales 2016 139 M
EBIT 2016 -66,1 M
Net income 2016 -74,9 M
Debt 2016 -
Yield 2016 -
Sales 2017 114 M
EBIT 2017 -66,3 M
Net income 2017 -75,2 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 2,58x
Capi. / Sales2017 3,13x
Capitalization 358 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products.It targets non-Hodgkin's lymphoma, advanced metastatic colorectal cancer, acute lymphoblastic leukemia, and multiple myeloma.It operates through... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
12/08 SPECTRUM PHARMACEUTICALS : Highlights Promising Preclinical Data Evaluating Pozi..
12/07 SPECTRUM PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Nevada (Dec. 7)
12/07 SPECTRUM PHARMACEUTICALS : Assigned Patent
12/06 SPECTRUM PHARMACEUTICALS : Highlights Survival Advantage in a Case Match Control..
12/05 SPECTRUM PHARMACEUTICALS : Highlights Five Abstracts on ROLONTIS™ (eflapeg..
12/02 SPECTRUM PHARMACEUTICALS : Highlights Four Abstracts at the 58th Annual Meeting ..
12/01 Continuing Challenges Hanmi Pharmaceutical Continues to Challenge for New Glo..
11/29 SPECTRUM PHARMACEUTICALS, INC. : Purcell Julie & Lefkowitz LLP Is Investigating ..
11/18 SPECTRUM PHARMACEUTICALS, INC. : 3-DAY DEADLINE: Khang & Khang LLP Announces Sec..
11/18 SPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K)
More news
Sector news : Biotechnology & Medical Research - NEC
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/18 FDA rejects Spectrum Pharma's NDA for QAPZOLA
11/14 Spectrum Pharma Q3 top line up 17%; net loss narrows
11/14 Spectrum Pharmaceuticals beats by $0.23, misses on revenue
11/04 After Hours Gainers / Losers
11/03 Spectrum Pharmaceuticals beats on revenue
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends SPECTRUM PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 9,00 $
Spread / Average Target 103%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Rajesh C. Shrotriya Chairman & Chief Executive Officer
Joseph G. Turgeon President & Chief Operating Officer
Kurt A. Gustafson Chief Financial Officer & Executive Vice President
Stuart Mitchell Krassner Independent Non-Employee Director
Anthony E. Maida Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SPECTRUM PHARMACEUTICA..-31.01%358
QUINTILES IMS HOLDINGS..14.10%19 286
INCYTE CORPORATION-7.21%18 957
CELLTRION, INC.--.--%9 997
LONZA GROUP AG9.20%9 261
SEATTLE GENETICS, INC.44.54%9 183
More Results